concentrate

Nearly 40% of adults globally are now considered obese, a figure projected to surpass 50% by 2030. But the story isn’t just about numbers on a scale anymore. A quiet revolution is underway, fueled by a class of drugs called GLP-1 receptor agonists, initially designed for diabetes, now reshaping our understanding – and treatment – … Read more